Tag: QNRX

Quoin Pharmaceuticals' Q4 Earnings Report Unveiled On March 13, 2024, Quoin Pharmaceuticals (NASDAQ: QNRX) disclosed its Q4 earnings, shedding light ...

AnaptysBio's shares have surged following an upgrade from Wedbush, who raised their rating from Neutral to Outperform. Analysts are bullish ...

Quoin Pharmaceuticals has recently been granted FDA approval to enroll teenagers in placebo and open-label trials for QRX003, a promising ...